[Federal Register: November 26, 2008 (Volume 73, Number 229)]
[Notices]
[Page 72042-72043]
[DOCID:fr26no08-70]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2008-0143; FRL-8390-6]

State Issues Research and Evaluation Group (SFIREG) Full
Committee; Notice of Public Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Association of American Pesticide Control Officials
(AAPCO)/State FIFRA Issues Research and Evaluation Group (SFIREG) Full
Committee will hold a 2-day meeting, beginning on December 8, 2008 and
ending December 9, 2008. This notice announces the location and times
for the meeting and sets forth the tentative agenda topics.

DATES: The meeting will be held on Monday, December 8, 2008 from 8:30
a.m. to 5:00 p.m. and 8:30 a.m to 12 noon on Tuesday December 9, 2008
    To request accommodation of a disability, please contact the person
listed under FOR FURTHER INFORMATON CONTACT, preferably at least 10
days prior to the meeting, to give EPA as much time as possible to
process your request.

ADDRESSES: The meeting will be held at EPA. One Potomac Yard (South
Bldg.) 2777 Crystal Dr., Arlington VA. 4th Floor South Conference Room.

FOR FURTHER INFORMATION CONTACT: Ronald Kendall, Field and External
Affairs Division (7506P), Office of Pesticide Programs, Environmental
Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-
0001; telephone number:<PHONE_NUMBER> fax number:<PHONE_NUMBER>; e-
mail address<EMAIL_ADDRESS>or Grier Stayton, SFIREG
Executive Secretary, P.O. Box 466, Milford DE 19963; telephone number
(302) 422-8152; fax<PHONE_NUMBER>; e-mail address: grierstaytonaapco-
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    You may be potentially affected by this action if you are
interested in SFIREG information exchange relationship with EPA
regarding important issues related to human health, environmental
exposure to pesticides, and insight into EPA's decision-making process.
You are invited and encouraged to attend the meetings and participate
as appropriate. Potentially affected entities may include, but are not
limited to:
    Those persons who are or may be required to conduct testing of
chemical substances under the Federal Food, Drug and Cosmetics Act
(FFDCA), or the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA).

B. How Can I Get Copies of this Document and Other Related Information?

    1. Docket. EPA has established a docket for this action under
docket ID number EPA-HQ-OPP-2008-0143. Publicly available docket
materials are available either in the electronic docket at http://
www.regulations.gov, or, if only available in hard copy, at the Office
of Pesticide Programs (OPP) Regulatory Public Docket in Rm. S-4400, One
Potomac Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The
hours of operation of this Docket Facility are from 8:30 a.m. to 4
p.m., Monday through Friday, excluding legal

holidays. The Docket Facility telephone number is<PHONE_NUMBER>.
    2. Electronic access. You may access this Federal Register document
electronically through the EPA Internet under the ``Federal Register''
listings at http://www.epa.gov/fedrgstr.

II. Background

    1. Regional Reports/Issues from the State Reps
    2. SFIREG Pesticide Operations and Management Working Committee
Meeting
    3. Pyrethroids, Picloram, AM HVAC Labeling, Registrant Stewardship
    4. Programs, Web Distributed Labeling
    5. Green labeling (stand alone with AMD), rodenticides, use by
statements
    6. SFIREG Water Quality and Pesticide Disposal Working Committee
Meeting
    7. Sampling, Analytical Methodology, Health risk from semi-volatile
pesticides, WC Name Change
    8. Registration Division Label Quality Assurance Update
    9. Thiencarbazone Label trial
    10. 25b Update
    11. Reg 1 Issue Paper, Green Labeling, HVAC
    12. Total Release Foggers
    13. Tribal Pesticide Program Council Update
    14. American Association of Pesticide Safety Educators Update
    15. Pesticide Regulatory Education Program Course Calendar
    16. Office of Pesticide Program Update
    17. Chemigation PR Notice, LAW
    18. Office of Enforcement and Compliance Program Update
    19. PIRT Schedule
    20. Regional Issue Paper Discussion

III. How Can I Request to Participate in this Meeting?

    You may submit a request to participate in this meeting to the
person listed under FOR FURTHER INFORMATION CONTACT. Do not submit any
information in your request that is considered CBI. Requests to
participate in the meeting, identified by docket ID number EPA-HQ-OPP-
2008-0143, must be received on or before October 21, 2008 Federal
Register.

List of Subjects

    Environmental protection.

    Dated: November 12, 2008.
William R. Diamond,
Director, Field and External Affairs Division, Office of Pesticide
Programs.
[FR Doc. E8-27758 Filed 11-25-08; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register Volume 79, Number 231 (Tuesday, December 2, 2014)]
[Notices]
[Pages 71434-71435]
[FR Doc No: 2014-28267]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2010-D-0194]

Infusion Pumps Total Product Life Cycle; Guidance for Industry
and Food and Drug Administration Staff; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Food and Drug Administration (FDA) is announcing the
availability of the final guidance entitled, ``Infusion Pumps Total
Product Life Cycle; Guidance for Industry and FDA Staff.'' The
recommendations in this guidance are intended to improve the safety and
effectiveness of these devices. This guidance also describes
considerations in preparing premarket submissions for infusion pumps
and identifies device features that manufacturers should address
throughout the total product life cycle.

DATES: Submit either electronic or written comments on this guidance at
any time. General comments on Agency guidance documents are welcome at
any time.

ADDRESSES: An electronic copy of the guidance document is available for
download from the Internet. See the SUPPLEMENTARY INFORMATION section
for information on electronic access to the guidance. Submit written
requests for a single hard copy of the guidance document entitled
``Infusion Pumps Total Product Life Cycle; Guidance for Industry and
FDA Staff'' to the Office of the Center Director, Guidance and Policy
Development, Center for Devices and Radiological Health, Food and Drug
Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 5431, Silver
Spring, MD 20993-0002. Send one self-addressed adhesive label to assist
that office in processing your request.
    Submit electronic comments on the guidance to http://www.regulations.gov. Submit written comments to the Division of Dockets
Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852. Identify comments with the docket number
found in brackets in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Alan Stevens, Center for Devices and
Radiological Health, Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 66, Rm. 2561, Silver Spring, MD 20993-0002,<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA has evaluated a broad spectrum of infusion pumps across
manufacturers and has encountered common problems with device software,
human factors, reliability, and manufacturing. Based on an evaluation
of reported adverse events and recalls, FDA believes that many injuries
and adverse events may be avoided by improving the design verification
and validation processes for infusion pump devices.
    The most frequently reported infusion pump device problems are:
Software error messages, human factors (which include, but are not
limited to, use error), broken components, battery failure, alarm
failure, over-infusion, and under-infusion. Subsequent analyses
revealed that many of these design problems could be corrected during
the design validation and verification processes.
    The Agency believes that this guidance provides recommendations
that will help mitigate observed risk and reduce potential risk
associated with infusion pumps. One method of improving the safety of
infusion pumps is the inclusion of safety assurance cases as part of
the premarket submissions for new, changed, or modified infusion pumps
submitted by device manufacturers. This guidance explains the Agency's
current thinking and provides recommendations on information to submit
through the safety assurance case framework and postmarket surveillance
of infusion pumps.
    In April 2010, the Agency issued the special control draft guidance
entitled ``Draft Guidance for Industry and FDA Staff: Total Product
Life Cycle: Infusion Pump--Premarket Notification [510(k)]
Submissions'' (Ref. 1). The Agency has reviewed the comments submitted
for the 2010 guidance and has incorporated most of the recommendations
in this final guidance.

II. Significance of Guidance

    This guidance is being issued consistent with FDA's good guidance
practices regulation (21 CFR 10.115). This guidance represents the
Agency's current thinking on infusion pumps. It does not create or
confer any rights for or on any person and does not operate to bind FDA
or the public. An alternative approach may be used if such approach
satisfies the requirements of the applicable statute and regulations.

III. Electronic Access

    Persons interested in obtaining a copy of the guidance may do so by
downloading an electronic copy from the Internet. A search capability
for all Center for Devices and Radiological Health guidance documents
is available at http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/default.htm. Guidance
documents are also available at http://www.regulations.gov. Persons
unable to download an electronic copy of ``Total Product Life Cycle:
Infusion Pumps; Guidance for Industry and FDA Staff'' may send an email
request to<EMAIL_ADDRESS>to receive an electronic copy of
the document. Please use the document number 1780 to identify the
guidance you are requesting.

IV. Paperwork Reduction Act

    Under the Paperwork Reduction Act (44 U.S.C. 3501-3520), Federal
Agencies must obtain approval from the Office of Management and Budget
(OMB) for each collection of information they conduct or sponsor. This
guidance also refers to previously approved information collections
found in FDA regulations. The collections of information in 21 CFR part
803 are approved under OMB control number 0910-0437; the collections of
information in 21 CFR part 801 are approved under OMB control number
0910-0485; the collections of information in 21 CFR part 812 are
approved under OMB control number 0910-0078; the collections of
information in 21 CFR part 807, subpart E are approved under OMB
control number 0910-0120; the collections of information in 21 CFR part
820 are approved under OMB control number 0910-0073; the collections of
information in 21 CFR part 822 are under OMB control number 0910-0449;
the collections of information in 21 CFR 56.115 are approved under OMB
control number 0910-0130; and the collections of information for safety
assurance cases are approved under OMB control number 0910-0766.

V. Comments

    Interested persons may submit either electronic comments regarding
this document to http://www.regulations.gov or written comments to the
Division of Dockets Management (see ADDRESSES). It is only necessary to
send one set of comments. Identify comments with the docket number
found in brackets in the heading of this document. Received comments
may be seen in the Division of Dockets Management between 9 a.m. and 4
p.m., Monday through Friday, and will be posted to the docket at http://www.regulations.gov.

VI. Reference

    The following reference has been placed on display in the Division
of Dockets Management (see ADDRESSES), and may be seen by interested
persons between 9 a.m. and 4 p.m., Monday through Friday, and is
available electronically at http://www.regulations.gov. (FDA has
verified the Web site address in this reference section, but we are not
responsible for any subsequent changes to the Web site after this
document publishes in the Federal Register.)

1. The FDA guidance entitled ``Draft Guidance for Industry and FDA
Staff: Total Product Life Cycle: Infusion Pump--Premarket Notification
[510(k)] Submissions,'' available at http://www.fda.gov/medicalDevices/DeviceRegulationandGuidance/GuidanceDocuments/ucm206153.htm.

    Dated: November 25, 2014.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2014-28267 Filed 12-1-14; 8:45 am]
BILLING CODE 4164-01-P


[Federal Register: April 2, 2007 (Volume 72, Number 62)]
[Notices]
[Page 15676]
[DOCID:fr02ap07-42]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. EL05-1-002]

Entergy Services, Inc.; Notice of Compliance Filing

March 27, 2007.
    Take notice that on March 22, 2007, Entergy Services, Inc.
(Entergy) acting as agent for Entergy Arkansas, Inc. tendered for
filing in compliance with the Commission's February 20, 2007 Order to
reclassify certain facilities identified in the Interconnection and
Operating Agreement between Entergy Arkansas and Union Power Partners,
L.P. as network upgrades eligible for transmission credits and interest
on such credits.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date. On or
before the comment date, it is not necessary to serve motions to
intervene or protests on persons other than the Applicant.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://www.ferc.gov.
 Persons unable to file electronically should submit an

original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on April 12, 2007.

Philis J. Posey,
Acting Secretary.
 [FR Doc. E7-5990 Filed 3-30-07; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 87, Number 201 (Wednesday, October 19, 2022)]
[Rules and Regulations]
[Pages 63426-63430]
[FR Doc No: 2022-22715]

=======================================================================
-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 271

[EPA-R08-RCRA-2022-0485; FRL 9896-02-R8]

North Dakota: Final Authorization of State Hazardous Waste
Management Program Revision

AGENCY: Environmental Protection Agency (EPA).

ACTION: Direct final rule.

-----------------------------------------------------------------------

SUMMARY: The State of North Dakota Department of Environmental Quality
(NDDEQ) has applied to the Environmental Protection Agency (EPA) for
final authorization of certain changes to its hazardous waste program
under the Resource Conservation and Recovery Act (RCRA). The EPA has
reviewed North Dakota's application and determined that North Dakota's
hazardous waste program revision satisfies all of the requirements
necessary to qualify for final authorization. EPA is authorizing the
State program revision through this direct final rule. EPA is
publishing this rule without prior proposal because the Agency views
this as a noncontroversial action and does not anticipate adverse
comments. However, in the proposed rules section of this issue of the
Federal Register, EPA is publishing a separate document that will serve
as a proposal to authorize the revision should the Agency receive
adverse comment. Unless EPA receives adverse written comments during
the review and comment period, the decision to authorize North Dakota's
hazardous waste program revision will take effect as provided below.

DATES: This final rule is effective on December 19, 2022 unless EPA
receives adverse written comment by November 18, 2022. Should EPA
receive such comments, it will publish a timely document by either:
withdrawing the direct final publication or affirming the publication
and responding to comments.

ADDRESSES: Submit your comments by one of the following methods:

     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the online instructions for submitting comments.
     Email: [email protected].
     Fax:<PHONE_NUMBER> (prior to faxing, please notify the
EPA contact listed below).
     Mail, Hand Delivery or Courier: Moye Lin, Resource
Conservation and Recovery Act Branch, EPA Region 8, Mail Code 8LCR-RC,
1595 Wynkoop Street, Denver, Colorado 80202-1129. Courier or hand
deliveries are only accepted during the Regional Office's normal hours
of operation. The public is advised to call in advance to verify
business hours. Special arrangements should be made for deliveries of
boxed information.
    Instructions: EPA must receive your comments by November 18, 2022.
Direct your comments to EPA-R08-RCRA-2022-0485; FR 9896-02-R8. The
EPA's policy is that all comments received will be included in the
public docket without change and may be made available online at
https://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information where
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through https://www.regulations.gov or email. The Federal website https://www.regulations.gov is an ``anonymous access'' system, which means EPA
will not know your identity or contact information unless you provide
it in the body of your comment. If you send an email comment directly
to EPA without going through https://www.regulations.gov, your email
address will be automatically captured and included as part of the
comment that is placed in the public docket and made available on the
internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment. If EPA cannot read your comment due to technical difficulties
and cannot contact you for clarification, EPA may not be able to
consider your comment. Electronic files should avoid the use of special
characters, any form of encryption and be free of any defects or
viruses.
    Docket: All documents in the docket are listed in the http://www.regulations.gov index. Although listed in the index, some
information is not publicly available, e.g., CBI or other information
where disclosure is restricted by statute. Certain other material, such
as copyrighted material, will be publicly available only in hard copy.
Publicly available docket materials are available electronically
through https://www.regulations.gov. For alternative access to docket
materials, please contact the person identified in the FOR FURTHER
INFORMATION CONTACT section.

FOR FURTHER INFORMATION CONTACT: Moye Lin, Land, Chemicals and
Redevelopment Division, EPA Region 8, 1595 Wynkoop Street, Denver,
Colorado 80202-1129; phone number<PHONE_NUMBER>; Email address:
[email protected].

SUPPLEMENTARY INFORMATION:

A. Why are revisions to State programs necessary?

    States which have received Final authorization from EPA under RCRA
section 3006(b), 42 U.S.C. 6926(b), must maintain a hazardous waste
program that is equivalent to, consistent with, and no less stringent
than the Federal program. As the Federal program changes, States must
change their programs and ask EPA to authorize the changes. Changes to
State programs may be necessary when Federal or State statutory or
regulatory authority is modified or when certain other changes occur.
Most commonly, States must change their programs because of changes to
EPA's regulations in 40 Code of Federal Regulations (CFR) parts 124,
260 through 268, 270, 273 and 279.

B. What decisions has EPA made in this rule?

    On October 29, 2021, the State of North Dakota submitted a final
complete program revision application seeking authorization of changes
to its

hazardous waste program that correspond to certain Federal rules
promulgated between July 1, 2016 through June 30, 2020, which includes
RCRA Cluster XXV through RCRA Cluster XXVIII (Revision Checklists 236,
237, 238, 239, 240, and 242), as well as State-initiated changes to the
State's previously authorized program. The EPA has reviewed North
Dakota's application to revise its authorized program and concludes
that it meets all of the statutory and regulatory requirements
established by RCRA, except for the final rule addressed by Revision
Checklist 241 (Management Standards for Hazardous Waste Pharmaceuticals
and Amendment to the P075 Listing for Nicotine) (84 FR 5816, February
22, 2019). EPA cannot authorize North Dakota for Revision Checklist 241
because the State has not correctly adopted the Federal changes
addressed by this final rule. Therefore, we grant North Dakota final
authorization to operate its hazardous waste program with the changes
described in the authorization application with the exception of
Revision Checklist 241.
    The State of North Dakota will continue to have responsibility for
permitting treatment, storage and disposal facilities (TSDFs) within
its borders (except in Indian country) and for carrying out the aspects
of the RCRA program described in its revised program application,
subject to the limitations of the Hazardous and Solid Waste Amendments
of 1984 (HSWA). New Federal requirements and prohibitions imposed by
Federal regulations that EPA promulgates under the authority of HSWA
take effect in authorized States before they are authorized for the
requirements. Thus, the EPA will implement those requirements and
prohibitions in the State of North Dakota, including issuing permits,
until the State is granted authorization to do so.

C. What is the effect of this authorization decision?

    If the State of North Dakota is authorized for these changes, a
facility in North Dakota subject to RCRA will now have to comply with
the authorized State requirements instead of the equivalent Federal
requirements in order to comply with RCRA. Additionally, such
facilities will have to comply with any applicable Federal requirements
such as, for example, HSWA regulations issued by the EPA for which the
State has not received authorization. The State of North Dakota will
continue to have enforcement responsibilities under its State hazardous
waste program for violations of such program, but the EPA retains its
authority under RCRA sections 3007, 3008, 3013 and 7003, which include,
among others, authority to:
     Conduct inspections and require monitoring, tests,
analyses, or reports;
     Enforce RCRA requirements and suspend or revoke permits,
and
     Take enforcement actions after notice to and consultation
with the State.
    The action to approve these provisions would not impose additional
requirements on the regulated community because the regulations for
which the State of North Dakota is requesting authorization are already
effective under State law and are not changed by the act of
authorization.

D. For what has North Dakota previously been authorized?

    North Dakota initially received final authorization on October 5,
1984, effective October 19, 1984 (49 FR 39328) to implement the RCRA
hazardous waste management program. We granted authorization for
changes to their program on: June 25, 1990, effective August 24, 1990
(55 FR 25836); May 4, 1992, effective July 6, 1992 (57 FR 19087); April
7, 1994, effective June 6, 1994 (59 FR 16566); January 19, 2000,
effective March 20, 2000 (65 FR 02897); September 26, 2005, effective
November 25, 2005 (70 FR 56132), February 14, 2008, effective April 14,
2008 (73 FR 8610), October 30, 2018, effective October 30, 2018 (83 FR
64521) and December 19, 2018, effective April 30, 2019 (83 FR 65101, as
revised on March 7, 2019, 84 FR 8260).
    The EPA incorporated by reference into the Code of Federal
Regulations the authorized North Dakota RCRA program on: February 14,
2008, effective April 14, 2008 (73 FR 8610); October 30, 2018,
effective October 30, 2018 (83 FR 54521), and December 12, 2019,
effective January 13, 2020 (84 FR 67875).

E. What changes is the EPA authorizing with this action?

    On October 29, 2021, the State of North Dakota submitted a final
complete program revision application, seeking authorization of their
changes in accordance with 40 CFR 271.21. We have determined that the
North Dakota Department of Environmental Quality's (NDDEQ's) hazardous
waste program revision satisfies all of the requirements necessary to
qualify for final authorization. We now make a Final decision, subject
to receipt of written comments that oppose this action, that North
Dakota's hazardous waste program satisfies all of the requirements
necessary to qualify for final authorization. The NDDEQ revisions
consist of regulations which specifically govern Federal hazardous
waste revisions promulgated between July 1, 2016 through June 30, 2020
(RCRA Clusters XXV through RCRA Cluster XXVIII), as well as State-
initiated changes to the State's previously authorized program. The
North Dakota provisions are from the North Dakota Administrative Code
(N.D.A.C.) Article 33.1-24, Hazardous Waste Management Rules, as
amended effective through July 1, 2021. We have determined that North
Dakota's hazardous waste program revision satisfies all of the
requirements necessary to qualify for Final authorization. Therefore,
we grant North Dakota DEQ final authorization for the following
changes:

1. Program Revision Changes for Federal Rules

    North Dakota seeks authority to administer the Federal requirements
that are listed below (the Federal rule citation is followed by the
analogs from the North Dakota Administrative Code (NDAC), Article 33.1-
24, as revised July 1, 2021):
    Import and Exports of Hazardous Waste (81 FR 85696, November 28,
2016; 82 FR 41015, August 29, 2017; and 83 FR 38263, August 6, 2018)
(Checklist 236)/33.1-24-01-04 ``AES filing compliance date,'' 33.1-24-
01-04 ``Electronic import-export reporting compliance date'', 33.1-24-
01-04 ``Recognized trader'', 33.1-24-01-05(7) introductory paragraph,
33.1-24-01-05(7)(a), 33.1-24-01-05(7)(b) [Reserved], 33.1-24-02-
04(4)(a), 33.1-24-02-04(4)(d), 33.1-24-02-04(5)(a), 33.1-24-02-
04(5)(d), 33.1-24-02-06(1)(c)(1), 33.1-24-02-06(1)(e), 33.1-24-02-
25(1)(e)(2), 33.1-24-02-25(1)(e)(5) introductory paragraph, 33.1-24-02-
25(1)(e)(5)(a)-(c)(7), 33.1-24-02-25(1)(e)(6), 33.1-24-02-25(1)(e)(9)-
(10), 33.1-24-03-01(5), 33.1-24-03-03(5), 33.1-24-03-14(3), 33.1-24-03-
17 [Repealed], 33.1-24-03-18 [Repealed], 33.1-24-03-19 [Repealed],
33.1-24-03-20 [Repealed], 33.1-24-03-21 [Repealed], 33.1-24-03-22
[Repealed], 33.1-24-03-23 [Repealed], 33.1-24-03-24 [Repealed], 33.1-
24-03-25 [Repealed], 33.1-24-03-30 [Repealed], 33.1-24-03-50(1)-(2),
33.1-24-03-51, 33.1-24-03-52, 33.1-24-03-53(1), 33.1-24-03-53(2)(a)
introductory paragraph, 33.1-24-03-53(2)(a)(1)-(13), 33.1-24-03-
53(2)(b)-(c), 33.1-24-03-53(2)(d), 33.1-24-03-53(2)(e)-(f), 33.1-24-03-
53(2)(g), 33.1-24-03-53(2)(h), 33.1-24-03-53(3)-(4)(b)(14), 33.1-24-03-
53(4)(b)(15),

33.1-24-03-53(5), 33.1-24-03-53(6)(a)-(c) introductory paragraph, 33.1-
24-03-53(6)(c)(1), 33.1-24-03-53(c)(2), 33.1-24-03-53(6)(d)-(e), 33.1-
24-03-53(6)(f) introductory paragraph-(f)(1), 33.1-24-03-53(6)(f)(2),
33.1-24-03-53(6)(g)-(i), 33.1-24-03-53(7)-(9), 33.1-24-03-55 [Removed
and replaced], 33.1-24-03-56 [Repealed], 33.1-24-03-57 [Repealed],
33.1-24-03-59 [Repealed], 33.1-24-04-01(4) introductory paragraph,
33.1-24-04-04(1)(b), 33.1-24-04-04(3), 33.1-24-04-04(5)(b), 33.1-24-04-
04(6)(b) and Note, 33.1-24-04-04(7), 33.1-24-05-03(1), 33.1-24-05-
38(1)(c), 33.1-24-05-230(2), 33.1-24-05-235 Table (a)(6)-(10), 33.1-24-
05-720, 33.1-24-05-739(1)-(2), 33.1-24-05-740, 33.1-24-05-756, 33.1-24-
05-762(1), 33.1-24-05-770 introductory paragraph-(3), 33.1-24-05-770(4)
[Removed], 33.1-24-05-1011(1)(d)-(f), 33.1-24-05-1011(4), 33.1-24-06-
16(5);
    Hazardous Waste Generator Improvements Rule (81 FR 86732, November
28, 2016) (Checklist 237)/33.1-24-01-04(5) ``Acute hazardous waste,''
33.1-24-01-04(23) ``Central accumulation area,'' 33.1-24-01-04(90)
``Large quantity generator,'' 33.1-24-01-04(107) ``Non-acute hazardous
waste,'' 33.1-24-01-04(134) ``Small quantity generator,'' 33.1-24-01-
04(167) ``Very small quantity generator,'' 33.1-24-01-05(4)(a), 33.1-
24-02-01(1) introductory paragraph-(1)(a), 33.1-24-02-01(3)(f), 33.1-
24-02-04(1)(g), 33.1-24-02-05 [Repealed], 33.1-24-02-06(3)(b)(4), 33.1-
24-02-18(5) introductory paragraph, 33.1-24-02-18(6) introductory
paragraph, 33.1-24-02-129(7), 33.1-24-03-01(1) introductory paragraph-
(b)(3), 33.1-24-03-01(1)(b)(4), 33.1-24-03-01(1)(b)(5)-(c)(3), 33.1-24-
03-01(1)(c)(4), 33.1-24-03-01(1)(c)(5)-(5), 33.1-24-03-01(11), 33.1-24-
03-02, 33.1-24-03-03(1)-(5), 33.1-24-03-03(13), 33.1-24-03-03(14),
33.1-24-03-10(2)-(4), 33.1-24-03-14, 33.1-24-03-16, 33.1-24-03-26,
33.1-24-03-27, 33.1-24-03-28, 33.1-24-03-29, 33.1-24-03-34, 33.1-24-03-
61(1) ``Central accumulation area'' [Removed], 33.1-24-03-61(11)
``Trained professional,'' 33.1-24-03-62(1)-(2), 33.1-24-03-63(1)-(2),
33.1-24-03-64(1), 33.1-24-03-64 (2)(b), 33.1-24-03-65, 33.1-24-03-
69(1)(a)-(b), 33.1-24-03-69(4)(b), 33.1-24-03-70(2), 33.1-24-03-
71(4)(b), 33.1-24-03-72(3)-(4), 33.1-24-03-72(5)(c), 33.1-24-03-
74(1)(a)-(c), 33.1-24-03-74(2)(b), 33.1-24-03-75(2)(e), 33.1-24-03-
77(1)-(2), 33.1-24-04-03, 33.1-24-05-01(6), 33.1-24-05-01(6)(c), 33.1-
24-05-06(2)(d), 33.1-24-05-15, 33.1-24-05-16, 33.1-24-05-17, 33.1-24-
05-18, 33.1-24-05-19, 33.1-24-05-20, 33.1-24-05-26, 33.1-24-05-27,
33.1-24-05-28, 33.1-24-05-29 introductory paragraph, 33.1-24-05-29(2)-
(3), 33.1-24-05-31, 3.1-24-05-32, 33.1-24-05-38(3), 33.1-24-05-42,
33.1-24-05-89, 33.1-24-05-93, 33.1-24-05-104(1), 33.1-24-05-183(1),
33.1-24-05-250(5)(a), 33.1-24-05-56(1)(e), 33.1-24-05-290(1)(a), 33.1-
24-05-290(1)(b)(1), 33.1-24-05-400(2)(b)-(c), 33.1-24-05-476(3)(d),
33.1-24-05-610(2)(c), 33.1-24-05-708(1)(b), 33.1-24-05-781(2), 33.1-24-
05-875(1), 33.1-24-05-1011(3), 33.1-24-06-16(5);
    Confidentiality Determinations for Hazardous Waste Export and
Import Document (82 FR 60894, December 26, 2017) (Checklist 238)/33.1-
24-01-16 introductory paragraph, 33.1-24-01-16(2)(c), 33.1-24-02-
25(1)(e)(4), 33.1-24-03-53(2)(e), 33.1-24-03-53(6)(i), 33.1-24-03-
55(2)(d), 33.1-24-03-55(6)(h);
    Hazardous Waste Electronic Manifest User Fee Rule (83 FR 420,
January 3, 2018) (Checklist 239)/33.1-24-03-04(7)(a)-(d), 33.1-24-03-
04(8), 33.1-24-03-04(1)-(1)(a), 33.1-24-03-05(6)(e)-(h), 33.1-24-03-
07(8)(c), 33.1-24-03-07(8)(e), 33.1-24-03-07(8)(g), 33.1-24-04-
04(1)(h), 33.1-24-04-05, 33.1-24-05-38(1)(b) introductory paragraph,
33.1-24-05-38(1)(b)(1)-(6), 33.1-24-05-38(10), 33.1-24-05-38(12), 33.1-
24-05-456(3)(d)(1), 33.1-24-05-45, 33.1-24-06-16(5);
    Safe Management of Recalled Airbags (83 FR 61552, November 30,
2018) (Checklist 240)/33.1-24-01-04(8) ``Airbag waste'', 33.1-24-01-
04(9) ``Airbag waste collection facility'', 33.1-24-01-04(10) ``Airbag
waste handler'', 33.1-24-02-04(10);
    Universal Waste Regulations: Addition of Aerosol Cans (84 FR 67202,
December 9, 2019) (Checklist 242)/33.1-24-01-04(161) ``Universal
waste'' (c)-(e), 33.1-24-01-04(162) ``Universal waste handler'' (b)(1),
33.1-24-05-701(1)(c)-(e), 33.1-24-05-01(6)(j)(3)-(5), 33.1-24-06-16(5),
33.1-24-05-250(6)(c)-(e), 33.1-24-05-703(2)(b), 33.1-24-05-706, 33.1-
24-05-709(4) ``Large quantity handler of universal waste,'' 33.1-24-01-
04(117) ``Pesticide'' (a)-(c), 33.1-24-05-709(1) ``Aerosol can,'' 33.1-
24-05-709(5) ``Small quantity handler of universal waste,'' 33.1-24-05-
713(3)(b)(3)-(4), 33.1-24-05-713(5)-(6), 33.1-24-05-732(2)(d), 33.1-24-
05-733(3)(b)(3)-(6).

2. State-Initiated Changes

    North Dakota has made amendments to its regulations that are not
directly related to any of the Federal rules addressed in Item E.1
above. These State-initiated changes are either conforming changes made
to existing authorized provisions or the adoption of provisions that
clarify and make the State's regulations internally consistent. The
State's regulations, as amended by these provisions, provide authority
which remains equivalent to and no less stringent than the Federal laws
and regulations. These State-initiated changes are submitted under the
requirements of 40 CFR 271.21(a) and include the following provisions
from the North Dakota Administrative Code (NDAC), Article 33.1-24, as
revised July 1, 2021: 33.1-24-01-05(1), and 33.1-24-05-42 introductory
paragraph [analogs to 40 CFR 260.11(a) and 264.75 introductory
paragraph, respectively].
    The State-initiated changes also include a conforming change to an
internal reference at the following citation: 33.1-24-02-04(5)(a)
[analog to 40 CFR 261.4(e)(1)].

F. Where are the revised State rules different from the Federal rules?

    When revised State rules differ from the Federal rules in the RCRA
State authorization process, EPA determines whether the State rules are
equivalent to, more stringent than, or broader in scope than the
Federal program. Pursuant to RCRA section 3009, 42 U.S.C. 6929, State
programs may contain requirements that are more stringent than the
Federal regulations. Such more stringent requirements can be federally
authorized and, once authorized, become federally enforceable. Although
the statute does not prevent States from adopting regulations that are
broader in scope than the Federal program, States cannot receive
Federal authorization for such regulations, and they are not federally
enforceable.
    We consider the following State requirements to be more stringent
than the Federal requirements: 33.1-24-02-25(1)(e)(6) [analog to 40 CFR
261.39(a)(5)(vi)], 33.1-24-03-53(2)(a) introductory paragraph [analog
to 40 CFR 262.83(b)(1) introductory paragraph], 33.1-24-03-53(2)(d)
[analog to 40 CFR 262.83(b)(4)], 33.1-24-03-53(2)(g) [analog to 40 CFR
262.83(b)(7)], 33.1-24-03-53(4)(b)(15) [analog to 40 CFR
262.83(d)(2)(xv)], 33.1-24-03-53(5) [analog to 40 CFR 262.83(e)], 33.1-
24-03-53(6)(c)(1) [analog to 40 CFR 262.83(f)(3)(i)], 33.1-24-03-
53(6)(d) [analog to 40 CFR 262.83(f)(4)], 33.1-24-03-53(6)(e) [analog
to 40 CFR 262.83(f)(5)], and 33.1-24-03-53(6)(f)(2) [analog to 40 CFR
262.83(f)(6)(ii)], because North Dakota requires documentation such as
manifests be submitted to the State in addition to the EPA; 33.1-24-03-
14 [in lieu of analogs to 40 CFR 262.18, 262.41, 262.44],

because North Dakota subjects both small and large quantity generators
to the biennial reporting requirements where the Federal allows small
quantity generators to comply with the less frequent re-notification
requirements; and 33.1-24-03-69(1)(a) and (1)(b) [analogs to 40 CFR
262.208(a)(1) and (a)(2)], because North Dakota requires academic labs
to remove containers of unwanted material in an interval not to exceed
six months rather than 12 as in the Federal program.
    There are no requirements that are broader in scope than the
Federal program in these revisions.

G. Who handles permits after the authorization takes effect?

    The State of North Dakota will continue to issue permits for all
the provisions for which it is authorized and will administer the
permits it issues. The EPA will continue to administer any RCRA
hazardous waste permits or portions of permits which we issued prior to
the effective date of this authorization. EPA will continue to
implement and issue permits for HSWA requirements for which North
Dakota is not yet authorized.

H. How does today's action affect Indian country (18 U.S.C. 1151) in
North Dakota?

    North Dakota is not authorized to carry out its hazardous waste
program in Indian country, as defined in 18 U.S.C. 1151. This includes,
but is not limited to:

1. Lands within the exterior boundaries of the following Indian
Reservations located within or abutting the State of North Dakota:
a. Fort Totten Indian Reservation
b. Fort Berthold Indian Reservation
c. Standing Rock Indian Reservation
d. Turtle Mountain Indian Reservation
2. Any land held in trust by the U.S. for an Indian tribe, and
3. Any other land, whether on or off a reservation, that qualifies as
Indian country within the meaning of 18 U.S.C. 1151.

    Therefore, this program revision does not extend to Indian country
where EPA will continue to implement and administer the RCRA program in
these lands.

I. What is codification and is the EPA codifying North Dakota's
hazardous waste program as authorized in this rule?

    Codification is the process of placing the State's statutes and
regulations that comprise the State's authorized hazardous waste
program into the CFR. We do this by referencing the authorized State
rules in 40 CFR part 272. We reserve the amendment of 40 CFR part 272,
subpart JJ for this authorization of North Dakota's program changes
until a later date. In this authorization application the EPA is not
codifying the rules documented in this Federal Register document.

J. Administrative Requirements

    The Office of Management and Budget (OMB) has exempted this action
(RCRA State Authorization) from the requirements of Executive Orders
12866 (58 FR 51735, October 4, 1993) and 13563 (76 FR 3821, January 21,
2011). Therefore, this action is not subject to review by OMB. This
action authorizes State requirements for the purpose of RCRA 3006, and
imposes no additional requirements beyond those imposed by State law.
Accordingly, this action will not have a significant economic impact on
a substantial number of small entities under the Regulatory Flexibility
Act (5 U.S.C. 601 et seq.). Because this action authorizes preexisting
requirements under State law and does not impose any additional
enforceable duty beyond that required by State law, it does not contain
any unfunded mandate or significantly or uniquely affect small
governments, as described in the Unfunded Mandates Reform Act of 1995
(Pub. L. 104-4). For the same reason, this action also does not
significantly or uniquely affect the communities of Tribal governments,
as specified by Executive Order 13175 (65 FR 67249, November 9, 2000).
This action will not have substantial direct effects on the States, on
the relationship between the national government and the States, or on
the distribution of power and responsibilities among the various levels
of government, as specified in Executive Order 13132 (64 FR 43255,
August 10, 1999), because it merely serves to authorize State
requirements as part of the State RCRA hazardous waste program without
altering the relationship or the distribution of power and
responsibilities established by RCRA.
    This action also is not subject to Executive Order 13045 (62 FR
19885, April 23, 1997), because it is not economically significant, and
it does not make decisions based on environmental health or safety
risks. This direct final rule is not subject to Executive Order 13211,
``Actions Concerning Regulations That Significantly Affect Energy
Supply, Distribution, or Use'' (66 FR 28355 (May 22, 2001)) because it
is not a significant regulatory action under Executive Order 12866.
    Under RCRA 3006(b), the EPA grants a State's application for
authorization as long as the State meets the criteria required by RCRA.
It would thus be inconsistent with applicable law for the EPA, when it
reviews a State authorization application; to require the use of any
particular voluntary consensus standard in place of another standard
that otherwise satisfies the requirements of RCRA. Thus, the
requirements of section 12(d) of the National Technology Transfer and
Advancement Act of 1995 (15 U.S.C. 272 note) do not apply. As required
by section 3 of Executive Order 12988 (61 FR 4729, February 7, 1996),
in issuing this rule, the EPA has taken the necessary steps to
eliminate drafting errors and ambiguity, minimize potential litigation,
and provide a clear legal standard for affected conduct. The EPA has
complied with Executive Order 12630 (53 FR 8859, March 15, 1988) by
examining the takings implications of the rule in accordance with the
``Attorney General's Supplemental Guidelines for the Evaluation of Risk
and Avoidance of Unanticipated Takings'' issued under the Executive
Order. This rule does not impose an information collection burden under
the provisions of the Paperwork Reduction Act of 1995 (44 U.S.C. 3501
et seq.).
    Executive Order 12898 (59 FR 7629, February 16, 1994) establishes
federal executive policy on environmental justice. Its main provision
directs Federal agencies, to the greatest extent practicable and
permitted by law, to make environmental justice part of their mission
by identifying and addressing, as appropriate, disproportionately high
and adverse human health or environmental effects of their programs,
policies, and activities on minority populations and low-income
populations in the United States. Because this rule authorizes pre-
existing State rules which are at least equivalent to, and no less
stringent than existing Federal requirements, and imposes no additional
requirements beyond those imposed by State law, and there are no
anticipated significant adverse human health or environmental effects,
the rule is not subject to Executive Order 12898.

List of Subjects in 40 CFR Parts 271

    Environmental protection, Administrative practice and procedure,
Confidential business information, Hazardous waste, Hazardous waste
transportation, Indian lands, Incorporation by reference,
Intergovernmental relations, Penalties, Reporting and recordkeeping
requirements.

    Authority: This action is issued under the authority of sections
2002(a), 3006, and

7004(b) of the Solid Waste Disposal Act as amended 42 U.S.C.
6912(a), 6926, 6974(b).

    Dated: October 11, 2022.
KC Becker,
Regional Administrator, Region 8.
[FR Doc. 2022-22715 Filed 10-18-22; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register: September 24, 2008 (Volume 73, Number 186)]
[Notices]
[Page 55065]
[DOCID:fr24se08-65]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER07-1194-001]

Castlebridge Energy Group LLC; Notice of Filing

September 17, 2008.
    Take notice that on September 11, 2008, Castlebridge Energy Group
LLC filed an amendment to its Determination of Category 1 Seller Status
filing, submitted to the Commission on August 13, 2008.
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date.
Anyone filing a motion to intervene or protest must serve a copy of
that document on the Applicant and all the parties in this proceeding.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://
www.ferc.gov. Persons unable to file electronically should submit an
original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on October 2, 2008.

Kimberly D. Bose,
Secretary.
 [FR Doc. E8-22266 Filed 9-23-08; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register: May 25, 2011 (Volume 76, Number 101)]
[Notices]
[Page 30343-30344]
[DOCID:fr25my11-69]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2011-0001; FRL-8874-4]

SFIREG Full Working Committee; Notice of Public Meeting

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Association of American Pesticide Control Officials
(AAPCO)/State FIFRA Issues Research and Evaluation Group (SFIREG) Full
Committee will hold a 2-day meeting, beginning on June 20, 2011 and
ending June 21, 2011. This notice announces the location and times for
the meeting and sets forth the tentative agenda topics.

DATES: The meeting will be held on Monday, June 20, 2011 from 8:30 a.m.
to 5 p.m. and 8:30 a.m. to noon on Tuesday, June 21, 2011.
    To request accommodation of a disability, please contact the person
listed under FOR FURTHER INFORMATION CONTACT, preferably at least 10
days prior to the meeting, to give EPA as much time as possible to
process your request.

ADDRESSES: The meeting will be held at EPA. One Potomac Yard (South
Bldg.) 2777 Crystal Dr., Arlington, VA, 1st Floor South Conference
Room.

FOR FURTHER INFORMATION CONTACT: Ron Kendall, Field External Affairs
Division, Office of Pesticide Programs, Environmental Protection
Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001;
telephone number:<PHONE_NUMBER>; e-mail address<EMAIL_ADDRESS>or Grier Stayton, SFIREG Executive Secretary, P.O. Box 466, Milford, DE
19963; telephone number<PHONE_NUMBER>; fax<PHONE_NUMBER>; e-mail
address: Grier Stayton at<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this action apply to me?

    You may be potentially affected by this action if you are
interested in pesticide regulation issues affecting States and any
discussion between EPA and SFIREG on FIFRA field implementation issues
related to human health, environmental exposure to pesticides, and
insight into EPA's decisionmaking process. You are invited and
encouraged to attend the meetings and participate as appropriate.
Potentially affected entities may include, but are not limited to:
    Those persons who are or may be required to conduct testing of
chemical substances under the Federal Food, Drug, and Cosmetic Act
(FFDCA), or the Federal Insecticide, Fungicide, and Rodenticide Act
(FIFRA) and those who sell, distribute or use pesticides, as well as
any Non Government Organization.
    This listing is not intended to be exhaustive, but rather provides
a guide for readers regarding entities likely to be affected by this
action. Other types of entities not listed in this unit could also be
affected. The North American Industrial Classification System (NAICS)
codes have been provided to assist you and others in determining
whether this action might apply to certain entities. If you have any
questions regarding the applicability of this action to a particular
entity, consult the person listed under FOR FURTHER INFORMATION
CONTACT.

B. How can I get copies of this document and other related information?

    EPA has established a docket for this action under docket ID number
EPA-HQ-OPP-2011-0001. Publicly available docket materials are available
either in the electronic docket at http://www.regulations.gov, or, if
only available in hard copy, at the Office of Pesticide Programs (OPP)
Regulatory Public Docket in Rm. S-4400, One Potomac Yard (South Bldg.),
2777 S. Crystal Dr., Arlington, VA. The hours of operation of this
Docket Facility are from 8:30 a.m. to 4 p.m., Monday through Friday,
excluding legal holidays. The Docket Facility telephone number is (703)
305-5805.

II. Tentative Agenda Topics

    1. Progress on Issue Papers:

    For Use by Statements, Expiration Dates; Supplemental Labeling.
    Revision of PR Notice 87-1 (Chemigation).
    2. Issues from Previous Meetings Updates and Discussion.
    3. Fumigation Label review process.
    4. Regional Report Summary, State Issues/New Issue Paper
Introduction.
    Endangered Species Act (ESA) Consultation.
    Bed Bug Control Product Risk/Efficacy/Cleanup.
    Drift Label Language Impacts.
    Office of Civil Rights/Revision of Inspection Procedures.
    5. SFIREG/USEPA Discussion.
    Incorporating SLA Program Priorities and Resources into EPA.
    Program priority setting.
    6. Working Committee Reports.
    Environmental Quality Issues (EQI) Working Committee Report.
    Pesticide Operations and Management (POM) Working Committee Report.
    7. Revision of State and Tribal Assistance Grants (STAG) Funding.
    8. Revised State Label Issues Tracking System (SLITS) process.
    9. Association of Structural Pest Control Regulatory Officials
Update.
    10. Association of American Pesticide Safety Educators (AAPSE)
Report.
    11. Tribal Pesticide Program Council (TPPC) Report.
    12. EPA/Office of Water--update on pesticide general permit.

III. How can I request to participate in this meeting?

    This meeting is open for the public to attend. You may attend the
meeting without further notification.

List of Subjects

    Environmental protection.

    Dated: May 5, 2011.
Robert C. McNally,
Acting Director, Field External Affairs Division, Office of Pesticide
Programs.
[FR Doc. 2011-12949 Filed 5-24-11; 8:45 am]
BILLING CODE 6560-50-P


[Federal Register Volume 75, Number 35 (Tuesday, February 23, 2010)]
[Notices]
[Page 8187]
[FR Doc No: 2010-3582]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket No. FMCSA-1999-6156; FMCSA-2003-15268; FMCSA-2005-22194; FMCSA-
2007-29019; FMCSA-2007-0017]

Qualification of Drivers; Exemption Renewals; Vision

AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.

ACTION: Notice of final disposition.

-----------------------------------------------------------------------

SUMMARY: FMCSA previously announced its decision to renew the
exemptions from the vision requirement in the Federal Motor Carrier
Safety Regulations for 27 individuals. FMCSA has statutory authority to
exempt individuals from the vision requirement if the exemptions
granted will not compromise safety. The Agency has concluded that
granting these exemptions will provide a level of safety that will be
equivalent to, or greater than, the level of safety maintained without
the exemptions for these commercial motor vehicle (CMV) drivers.

FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Director, Medical
Programs,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA, Department of
Transportation, 1200 New Jersey Avenue, SE., Room W64-224, Washington,
DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m. Monday through
Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

Electronic Access

    You may see all the comments online through the Federal Document
Management System (FDMS) at http://www.regulations.gov

Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
for a 2-year period if it finds ``such exemption would likely achieve a
level of safety that is equivalent to, or greater than, the level that
would be achieved absent such exemption.'' The statute also allows the
Agency to renew exemptions at the end of the 2-year period. The comment
period ended on January 11, 2010 (74 FR 65845).

Discussion of Comments

    FMCSA received no comments in this proceeding.

Conclusion

    The Agency has not received any adverse evidence on any of these
drivers that indicates that safety is being compromised. Based upon its
evaluation of the 27 renewal applications, FMCSA renews the Federal
vision exemptions for Thomas E. Anderson, Garry A. Baker, Bruce W.
Barrett, Richard D. Becotte, Wayne Burnett, Theodore W. Cozat, Alex G.
Dlugolenski, Karen Y. Duvall, Nigel L. Farmer, Gordon R. Fritz, John A.
Graham, Jimmy D. Gregory, Donald W. Holt, Larry Lentz, Boleslaw
Makowski, Joseph W. Meacham, Charles M. Moore, Gary T. Murray, Anthony
D. Ovitt, John R. Parsons, III, Martin Postma, Steven S. Reinsvold,
Michael J. Richard, Glenn T. Riley, George E. Todd, Gary S. Warren and
Bradley A. Weiser.
    In accordance with 49 U.S.C. 31136(e) and 31315, each renewal
exemption will be valid for 2 years unless revoked earlier by FMCSA.
The exemption will be revoked if: (1) The person fails to comply with
the terms and conditions of the exemption; (2) the exemption has
resulted in a lower level of safety than was maintained before it was
granted; or (3) continuation of the exemption would not be consistent
with the goals and objectives of 49 U.S.C. 31136 and 31315.

    Issued on: February 5, 2010.
Larry W. Minor,
Associate Administrator for Policy and Program Development.
[FR Doc. 2010-3582 Filed 2-22-10; 8:45 am]
BILLING CODE 4910-EX-P


[Federal Register: July 3, 2007 (Volume 72, Number 127)]
[Notices]
[Page 36442]
[DOCID:fr03jy07-49]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. QF07-129-000]

Tiqun Energy, Inc.; Notice of Self-Certification of Qualifying
Status of a Cogeneration Facility

June 26, 2007.
    Take notice that on June 23, 2007, Tiqun Energy, Inc. filed with
the Federal Energy Regulatory Commission a notice of self-certification
of a facility as a qualifying cogeneration facility pursuant to 18 CFR
292.207(a) of the Commission's regulations.
    The facility is a cogeneration facility with the primary energy
source being natural gas. The power production equipment will consist
of one GE LM6000PF Sprint gas turbine with a duct-fired heat recovery
steam generator driving one steam turbine generator for a total net
output capacity of 70 MWe. The facility will be located in Palmer,
Alaska.
    The Matanuska Electric Association, Inc. and the Chugach Electric
Association, Inc. are the electric utilities with which the facility
expects to interconnect, transmit or sell electric energy to, or
purchase supplementary, standby, back-up and maintenance power.
    A notice of self-certification [or self-recertification] does not
institute a proceeding regarding qualifying facility status; a notice
of self-certification [or self-recertification] provides notice that
the entity making filing has determined the Facility meets the
applicable criteria to be a qualifying facility. Any person seeking to
challenge such qualifying facility status may do so by filing a motion
pursuant to 18 CFR 292.207(d)(iii).
    This filing is accessible on-line at http://www.ferc.gov, using the

``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For

TTY, call<PHONE_NUMBER>.

Kimberly D. Bose,
Secretary.
 [FR Doc. E7-12805 Filed 7-2-07; 8:45 am]

BILLING CODE 6717-01-P


[Federal Register Volume 81, Number 133 (Tuesday, July 12, 2016)]
[Notices]
[Pages 45143-45144]
[FR Doc No: 2016-16392]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. ER16-2019-000]

Five Points Solar Park LLC; Supplemental Notice That Initial
Market-Based Rate Filing Includes Request for Blanket Section 204
Authorization

    This is a supplemental notice in the above-referenced proceeding of
Five Points Solar Park LLC`s application for market-based rate
authority, with an accompanying rate tariff, noting that such
application includes a request for blanket authorization, under 18 CFR
part 34, of future issuances of securities and assumptions of
liability.
    Any person desiring to intervene or to protest should file with the
Federal Energy Regulatory Commission, 888 First Street NE., Washington,
DC 20426, in accordance with Rules 211 and 214 of the Commission's
Rules of Practice and Procedure (18 CFR 385.211 and 385.214). Anyone
filing a motion to intervene or protest must serve a copy of that
document on the Applicant.
    Notice is hereby given that the deadline for filing protests with
regard to the applicant's request for blanket authorization, under 18
CFR part 34, of future issuances of securities and assumptions of
liability, is July 26, 2016.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper, using the FERC Online links at http://www.ferc.gov. To facilitate electronic service, persons with Internet
access who will eFile a document and/or be listed as a contact for an
intervenor must create and validate an eRegistration account using the
eRegistration link. Select the eFiling link to log on and submit the
intervention or protests.
    Persons unable to file electronically should submit an original and
5 copies of the intervention or protest to the Federal Energy
Regulatory Commission, 888 First Street NE., Washington, DC 20426.
    The filings in the above-referenced proceeding are accessible in
the Commission's eLibrary system by clicking on the appropriate link in
the above list. They are also available for electronic review in the
Commission's Public Reference Room in Washington, DC. There is an
eSubscription link on the Web site that enables subscribers to receive
email notification when a document is added to a subscribed docket(s).
For assistance with any FERC

Online service, please email<EMAIL_ADDRESS>or call (866)
208-3676 (toll free). For TTY, call<PHONE_NUMBER>.

    Dated: July 6, 2016.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2016-16392 Filed 7-11-16; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: May 25, 2010 (Volume 75, Number 100)]
[Notices]
[Page 29336]
[DOCID:fr25my10-53]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RM06-22-013]

North American Electric Reliability Corporation; Notice of Filing

May 18, 2010.
    Take notice that on May 17, 2010, North American Electric
Reliability Corporation (NERC) submitted revisions to 57 sets of
Violation Severity Level (VSL) assignments for Version 1 of the
Critical Infrastructure Protection (CIP) Reliability Standards, in
compliance with to the Commission's March 18, 2010 Order, Mandatory
Reliability Standards for Critical Infrastructure Protection, Order
Addressing Violation Severity Level Assignments for Critical
Infrastructure Protection Reliability Standards, 130 FERC ] 61,211 at
PP 23, 28, 31-33 (2010) (March 18 CIP VSL Order).
    Any person desiring to intervene or to protest this filing must
file in accordance with Rules 211 and 214 of the Commission's Rules of
Practice and Procedure (18 CFR 385.211, 385.214). Protests will be
considered by the Commission in determining the appropriate action to
be taken, but will not serve to make protestants parties to the
proceeding. Any person wishing to become a party must file a notice of
intervention or motion to intervene, as appropriate. Such notices,
motions, or protests must be filed on or before the comment date.
Anyone filing a motion to intervene or protest must serve a copy of
that document on the Applicant and all the parties in this proceeding.
    The Commission encourages electronic submission of protests and
interventions in lieu of paper using the ``eFiling'' link at http://
www.ferc.gov. Persons unable to file electronically should submit an
original and 14 copies of the protest or intervention to the Federal
Energy Regulatory Commission, 888 First Street, NE., Washington, DC
20426.
    This filing is accessible on-line at http://www.ferc.gov, using the
``eLibrary'' link and is available for review in the Commission's
Public Reference Room in Washington, DC. There is an ``eSubscription''
link on the Web site that enables subscribers to receive e-mail
notification when a document is added to a subscribed docket(s). For
assistance with any FERC Online service, please e-mail
<EMAIL_ADDRESS>or call<PHONE_NUMBER> (toll free). For
TTY, call<PHONE_NUMBER>.
    Comment Date: 5 p.m. Eastern Time on June 7, 2010.

Kimberly D. Bose,
Secretary.
[FR Doc. 2010-12504 Filed 5-24-10; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register Volume 83, Number 156 (Monday, August 13, 2018)]
[Notices]
[Pages 40057-40059]
[FR Doc No: 2018-17272]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2018-N-2455]

Patient-Focused Drug Development Guidance: Methods To Identify
What Is Important to Patients and Select, Develop, or Modify Fit-for-
Purpose Clinical Outcome Assessments; Public Workshop; Request for
Comments

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public workshop; request for comments.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a 2-day
public workshop to convene a discussion on methodological approaches
that may be used to identify what is most important to patients and
caregivers with respect to burden of disease, burden of treatment, and
the benefits and risks in the management of the patient's disease, and
best practices for selecting, developing, or modifying fit-for-purpose
clinical outcome assessments (COAs) to measure the patient experience
in clinical trials. This workshop will inform development of patient-
focused drug development guidance as required by the 21st Century Cures
Act (Cures Act) and as part of commitments made by FDA under the sixth
authorization of the Prescription Drug User Fee Act (PDUFA VI). FDA
will publish discussion documents approximately 1 month before the
workshop date. FDA is interested in seeking information and comments on
the approaches proposed in the discussion documents. FDA is also
interested in input on examples, which could be illustrated in the
draft guidance, where the approaches proposed in the discussion
document have been successfully applied.

DATES: The public workshop will be held on October 15 and 16, 2018,
from 9 a.m. to 5 p.m. Submit either electronic or written comments on
this public workshop by December 14, 2018. See the SUPPLEMENTARY
INFORMATION section for registration date and information.

ADDRESSES: The public workshop will be held at FDA's White Oak Campus,
10903 New Hampshire Ave., Bldg. 31 Conference Center, the Great Room
(Rm. 1503), Silver Spring, MD 20993. Entrance for the public workshop
participants (non-FDA employees) is through Building 1 where routine
security check procedures will be performed. For parking and security
information, please refer to https://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/ucm241740.htm.
Workshop updates, agenda, and discussion documents will be made
available at: https://www.fda.gov/Drugs/NewsEvents/ucm607276.htm prior
to the workshop.
    You may submit comments as follows. Please note that late, untimely
filed comments will not be considered. Electronic comments must be
submitted on or before December 14, 2018. The https://www.regulations.gov electronic filing system will accept comments until
midnight Eastern Time at the end of December 14, 2018. Comments
received by mail/hand delivery/courier (for written/paper submissions)
will be considered timely if they are postmarked or the delivery
service acceptance receipt is on or before that date.

Electronic Submissions

    Submit electronic comments in the following way:
     Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments. Comments submitted
electronically, including attachments, to https://www.regulations.gov
will be posted to the docket unchanged. Because your comment will be
made public, you are solely responsible for ensuring that your comment
does not include any confidential information that you or a third party
may not wish to be posted, such as medical information, your or anyone
else's Social Security number, or confidential business information,
such as a manufacturing process. Please note that if you include your
name, contact information, or other information that identifies you in
the body of your comments, that information will be posted on https://www.regulations.gov.
     If you want to submit a comment with confidential
information that you do not wish to be made available to the public,
submit the comment as a written/paper submission and in the manner
detailed (see ``Written/Paper Submissions'' and ``Instructions'').

Written/Paper Submissions

    Submit written/paper submissions as follows:
     Mail/Hand delivery/Courier (for written/paper
submissions): Dockets Management Staff (HFA-305), Food and Drug
Administration, 5630 Fishers Lane, Rm. 1061, Rockville, MD 20852.
     For written/paper comments submitted to the Dockets
Management Staff, FDA will post your comment, as well as any
attachments, except for information submitted, marked and identified,
as confidential, if submitted as detailed in ``Instructions.''
    Instructions: All submissions received must include the Docket No.
FDA-2018-N-2455 for ``Patient-Focused Drug Development Guidance:
Methods to Identify What is Important to Patients and Select, Develop
or Modify Fit-for-Purpose Clinical Outcome Assessments; Public
Workshop; Request for Comments.'' Received comments, those filed in a
timely manner (see ADDRESSES), will be placed in the docket and, except
for those submitted as ``Confidential Submissions,'' publicly viewable
at https://www.regulations.gov or at the Dockets Management Staff
between 9 a.m. and 4 p.m., Monday through Friday.
     Confidential Submissions--To submit a comment with
confidential information that you do not wish to be made publicly
available, submit your comments only as a written/paper submission. You
should submit two copies total. One copy will include the information
you claim to be confidential with a heading or cover note that states
``THIS DOCUMENT CONTAINS

CONFIDENTIAL INFORMATION.'' The Agency will review this copy, including
the claimed confidential information, in its consideration of comments.
The second copy, which will have the claimed confidential information
redacted/blacked out, will be available for public viewing and posted
on https://www.regulations.gov. Submit both copies to the Dockets
Management Staff. If you do not wish your name and contact information
to be made publicly available, you can provide this information on the
cover sheet and not in the body of your comments and you must identify
this information as ``confidential.'' Any information marked as
``confidential'' will not be disclosed except in accordance with 21 CFR
10.20 and other applicable disclosure law. For more information about
FDA's posting of comments to public dockets, see 80 FR 56469, September
18, 2015, or access the information at: https://www.gpo.gov/fdsys/pkg/FR-2015-09-18/pdf/2015-23389.pdf.
    Docket: For access to the docket to read background documents or
the electronic and written/paper comments received, go to https://www.regulations.gov and insert the docket number, found in brackets in
the heading of this document, into the ``Search'' box and follow the
prompts and/or go to the Dockets Management Staff, 5630 Fishers Lane,
Rm. 1061, Rockville, MD 20852.

FOR FURTHER INFORMATION CONTACT: Meghana Chalasani, Center for Drug
Evaluation and Research, Food and Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, Rm. 1146, Silver Spring, MD 20993-0002, 240-
402-6525, Fax:<PHONE_NUMBER>, [email protected].

SUPPLEMENTARY INFORMATION:

I. Background

    This public workshop is intended to support FDA implementation of
requirements for guidance development under section 3002 of the Cures
Act (Pub. L. 114-255) and to meet a performance goal included in the
sixth authorization of PDUFA VI. Section 3002 of Title III Subtitle A
of the Cures Act directs FDA to develop patient-focused drug
development guidance to address a number of areas including
methodological approaches that may be used to develop and identify what
is most important to patients with respect to burden of disease, burden
of treatment, and the benefits and risks in the management of the
patient's disease; and approaches to identifying and developing methods
to measure impacts to patients that will help facilitate collection of
patient experience data in clinical trials.
    In addition, FDA committed to meet certain performance goals under
PDUFA VI. This reauthorization, part of the FDA Reauthorization Act of
2017 signed by the President on August 18, 2017, includes a number of
performance goals and procedures that are documented in the PDUFA VI
Commitment Letter, which is available at https://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM511438.pdf. These goal
commitments were developed in consultation with patient and consumer
advocates, healthcare professionals, and other public stakeholders, as
part of negotiations with regulated industry. Section J.1 of the
commitment letter, ``Enhancing the Incorporation of the Patient's Voice
in Drug Development and Decision-Making,'' (https://www.fda.gov/downloads/ForIndustry/UserFees/PrescriptionDrugUserFee/UCM511438.pdf)
outlines work, including the development of a series of guidance
documents and associated public workshops to facilitate the advancement
and use of systematic approaches to collect and utilize robust and
meaningful patient and caregiver input that can more consistently
inform drug development, and, as appropriate, regulatory decision
making.
    Prior to the issuance of each guidance, as part of the development,
FDA will conduct a public workshop to gather input from the wider
community of patients, patient advocates, academic researchers, expert
practitioners, drug developers, and other stakeholders.

II. Purpose and Scope of Meeting

    FDA is announcing a 2-day public workshop to convene a discussion
on: (1) Methodological approaches that may be used to develop and
identify what is most important to patients and caregivers with respect
to burden of disease, burden of treatment, and the benefits and risks
in the management of the patient's disease and (2) best practices for
selecting, developing, or modifying fit-for-purpose COAs to measure the
patient experience in clinical trials. The purpose of this public
workshop is to obtain feedback from stakeholders on: (1) Methods to
identify what is important to patients; (2) best practices for
eliciting information on which aspects of disease symptoms, signs,
impacts, and other issues are important and meaningful to patients; (3)
measuring symptoms, signs, impacts and other issues of a disease or
condition in a meaningful way; and (4) selecting, developing, or
modifying fit-for-purpose COAs to measure the patient experience in
clinical trials. FDA is seeking information and comments from a broad
range of stakeholders, including patients, patient advocates, academic
and medical researchers, expert practitioners, drug developers, and
other interested persons. FDA will publish discussion documents
outlining the topic areas that will be addressed in the draft
guidances. These documents will be published approximately 1 month
before the workshop date on the website at: https://www.fda.gov/Drugs/NewsEvents/ucm607276.htm. FDA is interested in seeking information and
comments on the approaches and considerations proposed in the
discussion documents. FDA is also interested in seeking information and
comments on additional examples, which could be included in guidance,
where the approaches proposed in the discussion document have been
successfully applied. After this public workshop, FDA will take into
consideration the stakeholder input from the workshop and the public
docket and publish draft guidance(s).

III. Participating in the Public Workshop

    Registration: Interested parties are encouraged to register early.
To register electronically, please visit: https://pfddmethods.eventbrite.com. Registration for in-person attendance will
close on October 10, 2018. Registration for the webcast will remain
open until the day of the meeting. Persons without access to the
internet can call<PHONE_NUMBER> to register. If you are unable to attend
the meeting in person, you can register to view a live webcast of the
meeting. You will be asked to indicate in your registration if you plan
to attend in person or via the webcast. Seating will be limited, so
early registration is recommended. Registration is free and will be on
a first-come, first-served basis. However, FDA may limit the number of
participants from each organization based on space limitations.
Registrants will receive confirmation once they have been accepted.
Onsite registration on the day of the meeting will be based on space
availability.
    If you need special accommodations because of a disability, please
contact Meghana Chalasani (see FOR FURTHER INFORMATION CONTACT) at
least 7 days before the meeting.
    Request for Oral Presentations: There will be time allotted during
the workshop for open public comment. Sign-up for this session will be
on a first-come, first-served basis on the day of the workshop.
Individuals and

organizations with common interests are urged to consolidate or
coordinate, and request time for a joint presentation. No commercial or
promotional material will be permitted to be presented or distributed
at the public workshop.
    Transcripts: As soon as a transcript is available, FDA will post it
at https://www.fda.gov/Drugs/NewsEvents/ucm607276.htm.

    Dated: August 8, 2018.
Leslie Kux,
Associate Commissioner for Policy.
[FR Doc. 2018-17272 Filed 8-10-18; 8:45 am]
 BILLING CODE 4164-01-P


[Federal Register Volume 77, Number 123 (Tuesday, June 26, 2012)]
[Notices]
[Pages 38132-38133]
[FR Doc No: 2012-15292]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Pipeline and Hazardous Materials Safety Administration

[Docket No. PHMSA-2009-0203]

Pipeline Safety: Meeting of the Technical Pipeline Safety
Standards Committee and the Technical Hazardous Liquid Pipeline Safety
Standards Committee

AGENCY: Pipeline and Hazardous Materials Safety Administration (PHMSA),
DOT.

ACTION: Notice of advisory committee meetings.

-----------------------------------------------------------------------

SUMMARY: This notice announces a public meeting of the Technical
Pipeline Safety Standards Committee (TPSSC) and the Technical Hazardous
Liquid Pipeline Safety Standards Committee (THLPSSC). The committees
will meet to discuss a proposed rulemaking to make miscellaneous
changes to the pipeline safety regulations and to discuss several
future regulatory initiatives.

DATES: The TPSSC and the THLPSSC will meet in joint session on
Wednesday, July 11, 2012, from 9 a.m. to 5 p.m. The TPSSC and THLPSSC
will meet separately but simultaneously on Thursday, July 12 from 9
a.m. to 12 Noon followed by a second joint session from 1 p.m. to 4
p.m. EDT. The meeting will not be web cast; however, presentations will
be available on the meeting Web site and posted in the E-Gov Web Site:
http://www.regulations.gov under docket number PHMSA-2009-0203 within
30 days following the meeting.

ADDRESSES: The meeting will be held at the Marriott at Metro Center,
775 12th Street NW., Washington, DC 20005. The telephone number is 1-
800-228-9290: the local telephone number is<PHONE_NUMBER>. Additional
information about the hotel is available at: http://www.marriott.com/hotels/travel/WASMC-Washington-Marriott-at-Metro-Center. Any new
information or changes will be posted on the PHMSA Web page, (http://www.phmsa.dot.gov/public), under ``Latest News'' on the homepage.
    Comments on the meeting may be submitted to the docket in the
following ways:
    E-Gov Web Site: http://www.regulations.gov. This site allows the
public to enter comments on any Federal Register notice issued by any
agency.
    Fax: 1-202-493-2251.
    Mail: Docket Management Facility; U.S. Department of Transportation
(DOT), 1200 New Jersey Avenue SE., West Building, Room W12-140,
Washington, DC 20590-001.
    Hand Delivery: Room W12-140 on the ground level of the DOT West
Building, 1200 New Jersey Avenue SE., Washington, DC, between 9:00 a.m.
and 5:00 p.m., Monday through Friday, except Federal Holidays.
    Instructions: Identify the docket number PHMSA-2009-0203 at the
beginning of your comments. Note that all comments received will be
posted without change to http://www.regulations.gov, including any
personal information provided. You should know that anyone is able to
search the electronic form of all comments received into any of our
dockets by the name of the individual submitting the comment (or
signing the comment, if submitted on behalf of an association,
business, labor union, etc.). Therefore, you may want to review DOT's
complete Privacy Act Statement in the Federal Register published on
April 11, 2000 (65 FR 19477) or view the Privacy Notice at http://www.regulations.gov before submitting any such comments.
    Docket: For access to the docket or to read background documents or
comments, go to http://www.regulations.gov at any time or to Room W12-
140 on the ground level of the DOT West Building, 1200 New Jersey
Avenue SE., Washington, DC, between 9:00 a.m. and 5:00 p.m., Monday
through Friday, except Federal holidays.
    If you wish to receive confirmation of receipt of your written
comments, please include a self-addressed, stamped postcard with the
following statement: ``Comments on PHMSA-2009-0203.'' The Docket Clerk
will date-stamp the postcard prior to returning it to you via the U.S.
mail. Please note that due to delays in the delivery of U.S. mail to
Federal offices in Washington, DC, we recommend that persons consider
an alternative method (Internet, fax, or professional delivery service)
of submitting comments to the docket and ensuring their timely receipt
at DOT.

Privacy Act Statement

    Anyone may search the electronic form of comments received in
response to any of our dockets by the name of the individual who
submitted the comment (or signing the comment, if submitted on behalf
of an association, business, labor union, etc.). DOT's complete Privacy
Act Statement was published in the Federal Register on April 11, 2000
(65 FR 19477).

Information on Services for Individuals With Disabilities

    For information on facilities or services for individuals with
disabilities, or to seek special assistance at the meeting, please
contact Cheryl Whetsel at<PHONE_NUMBER> by July 5, 2012.

FOR FURTHER INFORMATION CONTACT: For information about the meeting,
contact Cheryl Whetsel by phone at<PHONE_NUMBER> or by email at
<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. Meeting Details

    Members of the public may attend and make a statement during the
advisory committee meeting. If you intend to make a statement, please
notify PHMSA in advance by forwarding an email to
<EMAIL_ADDRESS>by July 5, 2012.

II. Committee Background

    The TPSSC and THLPSSC are statutorily mandated advisory committees
that advise PHMSA on proposed safety standards, risks assessments, and
safety policies for natural gas pipelines and for hazardous liquid
pipelines. Both committees were established under the Federal Advisory
Committee Act (Pub. L. 92-463, 5 U.S.C. App. 1) and the pipeline safety
law (49 U.S.C. Chap. 601). Each committee consists of 15 members--with
membership evenly divided among the Federal and state government, the
regulated industry, and the public. The committees advise PHMSA on the
technical feasibility, practicability, and cost-effectiveness of each
proposed pipeline safety standard.

III. Agenda

    The Agenda is published on the PHMSA (DOT) Web site.

    Authority: 49 U.S.C. 60102, 60115; 60118.

    Issued in Washington, DC on June 18, 2012.
Linda Daugherty,
Deputy Associate Administrator for Policy and Programs.
[FR Doc. 2012-15292 Filed 6-25-12; 8:45 am]
BILLING CODE 4910-60-P